To the top of the page
Chapter 2.2.4
Module:  2.
Nutritional supplements bioactivity, functional properties and safety: in vitro & in vivo studies
Unit:  2.2.
Legislation issues about nutritional supplements use
Chapter:  2.2.4.
Evaluation of sources of nutrients

Whenever new substances are proposed for use as sources of nutrients in food supplements, foods for the general population or foods for specific groups, EFSA is requested by the European Commission to perform an assessment of their safety and of the bioavailability of the nutrient from the proposed source. The chemical substances used as sources which may be added to food, including food supplements and foods for specific groups, should be safe and also bioavailable, a property which is described, in the relevant legislation, as "available to be used by the body".

The use of chemical substances as "sources" of vitamins and minerals in food is regulated in the European Union (EU) by the establishment of positive lists of substances, annexed to the relevant sectorial legislation. In the next Table 2.2.5 is presented the new guidance document proposed by EFSA which refers to the data needed for the assessment of sources of nutrients proposed for use in the manufacture of foods.

Table 2.2.5. Guidance on safety evaluation of sources of nutrients and bioavailability of nutrient from the sources
Table 2.2.5. Guidance on safety evaluation of sources of nutrients and bioavailability of nutrient from the sources
Scientific data required to allow an evaluation of the safety of the source within the established framework for risk assessment and the bioavailability of the nutrient from this source.
Download the document here

For the safety assessment of the source, data requirements which should be covered in all applications relate to the description of the source, manufacturing process (including possible residuals or contaminants), technical specifications, proposed uses and use levels, and anticipated intake of the source and the corresponding intake of the nutrient. There are described the: